ADVERTISEMENT



Google       
Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> San Antonio Personal Injury Lawyer

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Personal Injury Law

: San Antonio Personal Injury Lawyer

Off-label Drugs Not Researched for Safety

By Beth Janicek

ADVERTISEMENTS

There is a recent study which has identified 14 drugs which needed the most pressing research into off-label use. The study says that physicians and patients should be most concerned about the antidepressants and the antipsychotic drugs on the list. The FDA only requires that the drug companies test the drugs for the use that they are seeking approval. For example on the list is Seroquel which has been approved by the FDA to treat schizophrenia and short term episodes of bipolar disease but the drug is more commonly prescribed as maintenance therapy for bipolar disease and yet there has not been ample research by the drug company for the FDA to approve the drug for this purpose. Therefore, it has not been proven to be safe for this treatment or effective.

Once a drug is approved by the FDA then according to PLoS Medicine, industry-paid "nationally known, influential academic physicians" help create "buzz" about off-label uses by writing about them for publication or presentation at scientific meetings.

This is of concern because many of these drugs have serious side effects. For example, Seroquel had added to its label the risk of diabetes and hyperglycemia. There may be other safety risks with these drugs that are unknown because there has not been sufficient testing.

Off-label use is legal and accounts for roughly half of all prescriptions written. I think the most important part is that patients need to be made aware that the drug they are being prescribed is for an off-label use so that they can make an informed decision on whether they want to use the drug. In a recent article in PLoS Medicine, the authors argued that the doctors had an ethical duty and an extension of informed consent to tell the patients about the off-label use. I could not agree more!

Originally posted at InjuryBoard by Beth Janicek

Full post as published by San Antonio Personal Injury Lawyer on November 27, 2008 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles
Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0022 secs (from cache 10/31/26 15:28:13)